Terumo(OTC) TRUMY

Current Price$13.25

Market Cap$19.54B

Since IPO (2009)+215%

5 Year-28%

1 Year-24%

1 Month-1%

Terumo last closing stock price
Metric	Price	Date
Last close	USD 13.25	2026-07-24

Terumo stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-5.09%	USD 13.96	2026-07-17
1 month	-1.49%	USD 13.45	2026-06-24
3 month	+3.11%	USD 12.85	2026-04-24
Year to date	-8.62%	USD 14.50	2025-12-31
1 year	-24.1%	USD 17.46	2025-07-24
3 year	-13.55%	USD 15.33	2023-07-25
5 year	-28.16%	USD 18.45	2021-07-23
Since inception	+214.77%	USD 4.21	2009-02-04

Terumo Financials at a Glance

Market Cap

$19.54B

Revenue (TTM)

¥1.15T

Net Income (TTM)

¥137.60B

EPS (TTM)

$0.61

P/E Ratio

21.54

Dividend

$0.19

Beta (Volatility)

0.67 (Low)

Dividend

$0.19

Beta (Volatility)

0.67 (Low)

Price

$13.25

Volume

173,546

Open

$13.20

Price

$13.25

Volume

173,546

Open

$13.20

Previous Close

$13.25

Daily Range

$13.15 - $13.27

52-Week Range

$12.08 - $19.60

Estimated Earnings Date

Aug 7, 2026

Dividend

$0.19

Beta (Volatility)

0.67 (Low)

Price

$13.25

Volume

173,546

Open

$13.20

Previous Close

$13.25

Daily Range

$13.15 - $13.27

52-Week Range

$12.08 - $19.60

Estimated Earnings Date

Aug 7, 2026

TRUMY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Terumo

Terumo Corporation is a global medical technology company focused on manufacturing and selling a diverse range of medical products and equipment. The company operates through three main segments: Cardiac and Vascular, Medical Care Solutions, and Blood and Cell Technologies.

Products and Services

Cardiac and vascular devices for interventions and treatments
General medical products including syringes and infusion systems
Innovative blood and cell management solutions

Growth Outlook

Revenue of 305.84 billion JPY in Q4 2026, showing consistent growth
Net income of 26.85 billion JPY in Q4 2026, reflecting strong profitability
Operating income margin of 11.39% in Q4 2026, indicating operational efficiency

Financial Highlights

Trailing twelve months (TTM) revenue of 1.14 trillion JPY
Net profit margin of 12.01% TTM, showcasing effective cost management
Dividend yield of 1.36% TTM, providing a return to shareholders

Terumo Corporation has established itself as a leader in the medical technology sector, with a strong focus on innovation and quality. The company's diverse product offerings cater to various medical needs, positioning it well for future growth. Recent financial performance indicates a robust revenue stream and profitability, which may attract potential investors looking for stability in the healthcare industry. The company's commitment to research and development further enhances its competitive edge, ensuring it remains at the forefront of medical advancements.

AI Generated • Jul 22, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

31,185

CEO

Hikaru Samejima, MBA

Website

www.terumo.co.jp

Headquarters

Tokyo, TY 151-0072, JP

TRUMY Financials

Key Financial Metrics (TTM)

Gross Margin

52.54%

Operating Margin

16.32%

Net Income Margin

12.01%

Return on Equity

9.19%

Return on Capital

9.93%

Return on Assets

5.88%

Earnings Yield

4.64%

Dividend Yield

1.43%

Payout Ratio

30.38%

Stock Overview

Market Cap

$19.54B

Shares Outstanding

1.48B

Volume

173.55K

Avg. Volume

189.83K

Financials (TTM)

Gross Profit

¥602.74B

Operating Income

¥189.49B

EBITDA

¥283.16B

Operating Cash Flow

¥235.03B

Capital Expenditure

-¥86.72B

Free Cash Flow

¥148.32B

Cash & ST Invst.

¥281.71B

Total Debt

¥381.44B

Terumo Performance Analysis

Terumo annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2023	2023-03-31	JPY 6,054,862,693	-3.3%
2024	2024-03-31	JPY 6,383,499,403	5.4%
2025	2025-03-31	JPY 6,796,776,038	6.5%
2026	2026-03-31	JPY 7,511,190,786	10.5%

Terumo sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2025-06-30	-1.5%
Q2	2025-09-30	7.6%
Q3	2025-12-31	7.9%
Q4	2026-03-31	1.3%

Terumo annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2023	2023-03-31	JPY 0.44	-15.9%
2024	2024-03-31	JPY 0.49	12.7%
2025	2025-03-31	JPY 0.52	4.7%
2026	2026-03-31	JPY 0.61	18.0%

Terumo sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q1	2025-06-30	128.0%
Q2	2025-09-30	-15.4%
Q3	2025-12-31	-8.5%
Q4	2026-03-31	-19.9%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2026YOY CHG

Revenue

¥305.84B

+15.9%

Gross Profit

¥151.76B

+9.5%

Gross Margin

49.62%

N/A

Market Cap

$19.54B

N/A

Market Cap/Employee

$647.03K

N/A

Employees

30,207

N/A

Net Income

¥26.85B

+46.3%

EBITDA

¥61.75B

-4.0%

Quarterly Fundamentals

Name

Q4 2026YOY CHG

Total Cash

¥281.71B

+26.7%

Total Debt

¥381.44B

+118.2%

Accounts Receivable

¥218.51B

+23.6%

Inventory

¥337.09B

+14.5%

Long Term Debt

¥100.34B

-37.2%

Short Term Debt

¥281.10B

+1774.0%

Return on Assets

5.88%

N/A

Return on Invested Capital

10.43%

N/A

Free Cash Flow

¥54.43B

+33.3%

Operating Cash Flow

¥90.32B

+35.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SAUHFStraumann Holding AG

SAUHFStraumann Holding AG$118.30-2.99%

SDMHFSartorius Stedim Biotech S.A.

SDMHFSartorius Stedim Biotech S.A.$193.00+0.52%

SAUHYStraumann Holding AG

SAUHYStraumann Holding AG$11.64-1.02%

SUVPFSartorius AG

SUVPFSartorius AG$256.25+0.00%

CLPBYColoplast A/S

CLPBYColoplast A/S$6.19+2.48%

CLPBFColoplast A/S

CLPBFColoplast A/S$64.00+0.00%

OTSKFOtsuka Holdings Co., Ltd.

OTSKFOtsuka Holdings Co., Ltd.$66.50+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

INTCIntel

INTCIntel$92.32-0.08%

NOKNokia

NOKNokia$9.10-0.06%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$7.42-0.04%

ONDSOndas

ONDSOndas$7.80-0.02%

SOFISoFi Technologies

SOFISoFi Technologies$16.46-0.01%

NUNu Holdings

NUNu Holdings$14.09-0.01%

AALAmerican Airlines Group

AALAmerican Airlines Group$14.48+0.07%

Questions About TRUMY

What is the current price of Terumo?

Terumo is trading at $13.25 per share.

What is the 52-week range for Terumo?

Over the past 52 weeks, Terumo has traded between $12.08 and $19.60.

How much debt does Terumo have?

As of the most recent reporting period, Terumo reported total debt of ¥2.69B.

How much cash does Terumo have on hand?

Terumo reported ¥1.76B in cash and cash equivalents in its most recent financial results.

What is Terumo’s dividend yield?

Terumo currently has a dividend yield of 1.43%.

Terumo(OTC) TRUMY

Terumo Financials at a Glance

TRUMY News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Terumo

TRUMY Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Terumo Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About TRUMY

What is the current price of Terumo?

What is the 52-week range for Terumo?

How much debt does Terumo have?

How much cash does Terumo have on hand?

What is Terumo’s dividend yield?

Premium Investing Services